4//SEC Filing
Stilley William B. III 4
Accession 0001213900-23-043129
CIK 0001513525other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 4:47 PM ET
Size
7.1 KB
Accession
0001213900-23-043129
Insider Transaction Report
Form 4
Stilley William B. III
DirectorChief Executive Officer10% Owner
Transactions
- Award
Common Stock
2023-05-23+240,800→ 1,261,779 total - Award
Stock Option (Right to Buy)
2023-05-23+50,000→ 50,000 totalExercise: $0.30From: 2023-05-23Exp: 2033-05-23→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023.
Documents
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeother
Related Parties
1- filerCIK 0001718069
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 4:47 PM ET
- Size
- 7.1 KB